サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1739329

がん保険の世界市場

Cancer Insurance

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.12円
がん保険の世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がん保険の世界市場は2030年までに1,420億米ドルに到達

2024年に809億米ドルと推定されるがん保険の世界市場は、2024年から2030年にかけてCAGR 9.8%で成長し、2030年には1,420億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである個人保険プランは、CAGR 11.3%を記録し、分析期間終了時には871億米ドルに達すると予測されます。補足保険プラン分野の成長率は、分析期間中CAGR 7.5%と推定されます。

米国市場は213億米ドルと推定、中国はCAGR 9.4%で成長予測

米国のがん保険市場は、2024年に213億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに225億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.2%と8.2%と予測されています。欧州では、ドイツがCAGR約7.7%で成長すると予測されています。

世界のがん保険市場- 主要動向と促進要因のまとめ

がん保険が個人のファイナンシャルプランニングや健康リスク対策において戦略的重要性を増している理由とは？

がん保険は、世界のがん罹患率の上昇と、がんの診断、治療、長期管理に関連する高額な自己負担費用に対応するため、経済的保障として不可欠なレイヤーとなりつつあります。標準的な医療保険とは異なり、がんに特化した保険は、医療費、治療のための渡航費、収入減、またはサポート・ケアに柔軟に使用できる一時金または払い戻しを提供するように設計されています。先進国市場でも新興国市場でも、がんの罹患率が上昇するにつれて、個人や家族は、重大な疾病が発生した場合の経済的変動を軽減するために、特化した保険の価値を認識しつつあります。

がんの診断、治療期間、治療費（化学療法、放射線療法、免疫療法、標的治療薬など）は予測不可能であるため、単独または付加的ながん保険保険の重要性が増しています。ヘルスケア、保険会社、ファイナンシャル・アドバイザーは、総合的な健康・ウェルネス・プランニングの一環としてがん保険を推奨するようになってきています。

製品イノベーションとデジタル流通は、がん保険ソリューションへのアクセスをどのように拡大していますか？

保険会社は、がんのステージ、タイプ、再発の状態に応じた保障を提供するなど、さまざまな層のニーズに応えるモジュール型や段階型のがん保険商品を発売しています。現在では、早期診断給付金、所得代替給付金、住宅改造や緩和ケアなどの非医療費の補償も含まれています。また、セカンド・オピニオン・サービス、遠隔腫瘍学サポート、がん予防とサバイバーシップのためのウェルネス・プログラムを統合したプランもあります。

デジタル・プラットフォームは、より透明で迅速な商品発見、見積もり作成、保険証券発行を促進しています。モバイルアプリ、オンライン計算機、AIベースのリスク評価ツールは、顧客エンゲージメントを強化し、高リスクグループ向けのターゲットマーケティングを可能にしています。クレジットカード、デジタル・ウォレット、雇用者の福利厚生プログラムなどとバンドルされた組み込み型保険は、特に浸透していないセグメントにおいて、さらにリーチを拡大しています。これらのイノベーションは参入障壁を低くし、がん保険をパーソナライゼーションと利便性に関して進化する消費者の期待に沿うものにしています。

がん保険の需要はどこで高まり、どの市場セグメントが普及を牽引しているか？

北米と欧州の一部では、がん保険の成熟市場が続いており、高いヘルスケアコストと標準的な保険プランとのギャップがそれを支えています。がん治療費が6桁を超えることもある米国では、がん保険は中間所得層や退職者層向けに販売されるのが一般的です。欧州では、雇用主がスポンサーとなるプランや、任意の上乗せ補償モデルを通じて、緩やかな取り込みが見られます。

アジア太平洋地域は、インド、中国、インドネシア、フィリピンなどの市場におけるがん罹患率の急増、ヘルスケア意識の高まり、保険未加入を背景に、高成長地域として浮上しています。これらの地域の保険会社は、中産階級の消費者、ギグワーカー、農村部の人々をターゲットに、バンカシュアランス、モバイルネットワーク、フィンテック・プラットフォームを通じて、手頃で簡素化された商品を販売しています。特に、初めて保険に加入する人の間で、大きな影響を与える健康イベントに対する低保険料の保障を求める需要が強いです。

がん保険市場の世界的成長の原動力は？

世界のがん保険市場は、がん罹患率の上昇、金融リテラシーの向上、健康リスク管理のツールとしての保険の認知度向上を背景に拡大しています。人口の高齢化、都市部でのライフスタイルの変化、環境的なリスク要因ががん罹患率を上昇させる一方、医療インフレは多くの地域で所得の伸びを上回り続けています。その結果、保険会社はがんに特化した商品を、より広範な健康保険や経済的保障のポートフォリオの中で重要なセーフガードとして位置づけています。

保険会社、病院、デジタルヘルス・プラットフォーム間の戦略的提携は、保険金請求処理、早期発見イニシアティブ、治療ナビゲーションを強化し、がん保険の価値提案を強化しています。マイクロインシュランス（小規模保険）、商品の標準化、デジタルオンボーディングに対する規制当局の支援も、価格に敏感な市場への浸透を可能にしています。がんが経済的に重大な影響を及ぼす長期的な健康課題となっている今、市場の軌道を形作る決定的な課題があります。情勢が急速に変化するヘルスケア環境の中で、予防、早期発見、サバイバーシップをサポートしながら、有意義な経済的保障を提供する包括的で、迅速な、データ主導型のソリューションへと進化することができるのでしょうか？

セグメント

保険プラン（個人プラン、補足プラン、重大疾病プラン）;性別（男性、女性）

調査対象企業の例（全32件）

  • Aegon N.V.
  • Aflac Incorporated
  • Allianz SE
  • American Fidelity Assurance Company
  • Anthem, Inc.
  • Aviva plc
  • AXA S.A.
  • Bajaj Allianz General Insurance
  • Bharti AXA General Insurance
  • Blue Cross Blue Shield Association
  • Cigna Corporation
  • Colonial Life & Accident Insurance
  • Desjardins Group
  • ICICI Prudential Life Insurance
  • Kaiser Permanente
  • Liberty Mutual Insurance
  • ManipalCigna Health Insurance
  • Max Life Insurance Company Limited
  • MetLife, Inc.
  • Mutual of Omaha Insurance Company

関税影響係数

Global Industry Analystsは、本社国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33588

Global Cancer Insurance Market to Reach US$142.0 Billion by 2030

The global market for Cancer Insurance estimated at US$80.9 Billion in the year 2024, is expected to reach US$142.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Individual Insurance Plan, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$87.1 Billion by the end of the analysis period. Growth in the Supplement Insurance Plan segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.3 Billion While China is Forecast to Grow at 9.4% CAGR

The Cancer Insurance market in the U.S. is estimated at US$21.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$22.5 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Cancer Insurance Market - Key Trends & Drivers Summarized

Why Is Cancer Insurance Gaining Strategic Importance in Personal Financial Planning and Health Risk Protection?

Cancer insurance is becoming an essential layer of financial protection in response to the rising global burden of cancer and the high out-of-pocket costs associated with its diagnosis, treatment, and long-term management. Unlike standard health insurance, cancer-specific policies are designed to provide lump-sum payouts or reimbursements that can be used flexibly-for medical expenses, travel for treatment, loss of income, or supportive care. As cancer incidence increases across both developed and emerging markets, individuals and families are recognizing the value of specialized insurance to mitigate the financial volatility of a critical illness event.

The unpredictable nature of cancer diagnosis, treatment duration, and therapy costs-including chemotherapy, radiation, immunotherapy, and targeted drugs-underscores the relevance of standalone or supplemental cancer insurance policies. Employers, insurers, and financial advisors are increasingly recommending cancer insurance as part of comprehensive health and wellness planning, especially for high-risk individuals, aging populations, or those with limited access to universal healthcare.

How Are Product Innovation and Digital Distribution Expanding Access to Cancer Insurance Solutions?

Insurers are launching modular and tiered cancer insurance products that cater to varied demographic needs, offering coverage based on cancer stage, type, or recurrence status. Policies now include early diagnosis benefits, income replacement, and coverage for non-medical expenses such as home modifications and palliative care. Some plans also integrate second-opinion services, tele-oncology support, and wellness programs for cancer prevention and survivorship.

Digital platforms are driving product discovery, quote generation, and policy issuance with greater transparency and speed. Mobile apps, online calculators, and AI-based risk assessment tools are enhancing customer engagement and enabling targeted marketing for high-risk groups. Embedded insurance offerings-bundled with credit cards, digital wallets, or employer benefit programs-are further expanding reach, particularly in underpenetrated segments. These innovations are lowering barriers to entry and aligning cancer insurance with evolving consumer expectations around personalization and convenience.

Where Is Demand for Cancer Insurance Rising and Which Market Segments Are Driving Uptake?

North America and parts of Europe remain mature markets for cancer insurance, supported by high healthcare costs and gaps in standard insurance plans. In the U.S., where cancer treatment expenses can easily exceed six figures, supplemental cancer policies are commonly marketed to middle-income and retiree demographics. Europe sees moderate uptake through employer-sponsored plans and voluntary top-up coverage models.

Asia-Pacific is emerging as a high-growth region, driven by rapidly increasing cancer incidence, rising healthcare awareness, and underinsurance in markets such as India, China, Indonesia, and the Philippines. Insurers in these regions are targeting middle-class consumers, gig workers, and rural populations with affordable, simplified products distributed via bancassurance, mobile networks, and fintech platforms. Demand is especially strong among first-time policyholders seeking low-premium protection against high-impact health events.

What Is Fueling the Global Growth of the Cancer Insurance Market?

The global cancer insurance market is expanding on the back of rising cancer prevalence, increasing financial literacy, and the growing recognition of insurance as a tool for health risk management. Aging populations, urban lifestyle shifts, and environmental risk factors are driving cancer rates upward, while medical inflation continues to outpace income growth in many regions. As a result, insurers are positioning cancer-specific products as critical safeguards within broader health and financial security portfolios.

Strategic alliances between insurers, hospitals, and digital health platforms are enhancing claims processing, early detection initiatives, and treatment navigation-strengthening the value proposition of cancer insurance. Regulatory support for microinsurance, product standardization, and digital onboarding is also enabling penetration in price-sensitive markets. As cancer becomes a long-term health challenge with significant economic implications, a defining question shapes the market’s trajectory: Can cancer insurance evolve into an inclusive, responsive, and data-driven solution that delivers meaningful financial protection-while supporting prevention, early detection, and survivorship in a rapidly changing healthcare landscape?

SCOPE OF STUDY:

The report analyzes the Cancer Insurance market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Insurance Plan (Individual Plan, Supplement Plan, Critical Illness Plan); Gender (Male, Female)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Aegon N.V.
  • Aflac Incorporated
  • Allianz SE
  • American Fidelity Assurance Company
  • Anthem, Inc.
  • Aviva plc
  • AXA S.A.
  • Bajaj Allianz General Insurance
  • Bharti AXA General Insurance
  • Blue Cross Blue Shield Association
  • Cigna Corporation
  • Colonial Life & Accident Insurance
  • Desjardins Group
  • ICICI Prudential Life Insurance
  • Kaiser Permanente
  • Liberty Mutual Insurance
  • ManipalCigna Health Insurance
  • Max Life Insurance Company Limited
  • MetLife, Inc.
  • Mutual of Omaha Insurance Company

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cancer Insurance - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Cancer Incidence and Treatment Costs Spur Demand for Specialized Cancer Insurance Products
    • Lump Sum Payout Models Offer Financial Flexibility for Out-of-Pocket Cancer Treatment Expenses
    • Policy Riders for Critical Illness and Hospital Cash Expand Customization Options in Cancer Plans
    • Insurers Launch Digital Cancer Coverage With Early Diagnosis Incentives and Wellness Features
    • Integration With Tele-Oncology Services and Navigation Support Adds Value for Policyholders
    • Employer-Provided Cancer Insurance Plans Grow in Popularity as Part of Enhanced Health Benefits
    • Consumer Awareness Campaigns Improve Understanding of Coverage Scope and Claim Triggers
    • Cancer Insurance Policies Gain Traction in Regions With Limited Universal Healthcare Coverage
    • Cross-Selling With Life and Health Insurance Portfolios Supports Customer Retention Strategies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cancer Insurance Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cancer Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cancer Insurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Individual Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Individual Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Supplement Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Supplement Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Critical Illness Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Critical Illness Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • JAPAN
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Japan 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • CHINA
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: China 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • EUROPE
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Cancer Insurance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • FRANCE
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • GERMANY
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Germany 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Italy 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of World 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030

IV. COMPETITION